Unichem Laboratories is currently trading at Rs. 175.80, up by 5.85 points or 3.44% from its previous closing of Rs. 169.95 on the BSE.
The scrip opened at Rs. 171.10 and has touched a high and low of Rs. 178.65 and Rs. 169.80 respectively. So far 4621 shares were traded on the counter.
The BSE group ‘B’ stock of face value Rs. 2 has touched a 52 week high of Rs. 239.75 on 10-Sep-2018 and a 52 week low of Rs. 158.35 on 31-Jul-2019.
Last one week high and low of the scrip stood at Rs. 178.65 and Rs. 169.40 respectively. The current market cap of the company is Rs. 1195.49 crore.
The promoters holding in the company stood at 50.62%, while Institutions and Non-Institutions held 9.49% and 39.88% respectively.
United States Food and Drug Administration (USFDA) has conducted inspection at the Unichem Laboratories’ Pithampur, Active Pharmaceutical Ingredients (APIs) facility from September 02, 2019 to September 05, 2019. The inspection was a post approval inspection and successfully concluded without any USFDA form 483 issued.
Unichem Laboratories is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world.